Advisory
AHA Advisories provide urgent information for AHA members and the health care field, and actions they may need to take.
Hospitals That Are Oracle Customers Urged to Take Immediate Action to Address Security Vulnerability
Oracle has published a Security Alert that addresses vulnerability CVE-2025-61882 in the Oracle E-Business Suite (EBS). This vulnerability is remotely exploitable without authentication, i.e., it may be exploited over a network without the need for a username and password. If successfully exploited…
Government funding and certain health care programs and waivers expired at midnight Sept. 30 as congressional leaders were unable to reach an agreement to keep the government funded.
A federal government shutdown began at midnight Sept. 30. The impact on health care is that government funding and certain health care programs and waivers expired.
The AHA today asked the administration to provide exemptions for health care personnel from the
proclamation issued Sept. 19, 2025, announcing changes to the H-1B visa program.
Advisory revised Sept 28. with fiscal year 2026 agency contingency plans. Government funding is set to expire at midnight Sept. 30 without congressional action.
As part of the AHA’s long-standing commitment to helping hospitals and health systems defend against and deflect cyberattacks, the AHA and Microsoft announced this week several new and updated offerings as part of the Rural Health Resiliency program.
Government funding is set to expire at midnight Sept. 30 without congressional action.
The Department of Homeland Security (DHS), under the U.S. Citizenship and
Immigration Services (USCIS), Sept. 23 issued a proposed rule to amend the process
for selecting among prospective employees for H-1B visas that are subject to statutory
numerical caps.
President Trump Sept. 19 signed a proclamation increasing the fee to $100,000 for new H-1B petitions filed by employers, as well as implementing other restrictions on entry of certain nonimmigrant workers.
The AHA appreciates that the FDA and the federal district court have acknowledged the unique value and safety of laboratory tests developed by hospitals and health systems for direct use in patient care.